Central Pharmaceutical No3 (DP3) Stock Overview
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
DP3 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Central Pharmaceutical Joint Stock Company No3 Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫61,000.00 |
| 52 Week High | ₫67,500.00 |
| 52 Week Low | ₫47,000.00 |
| Beta | 0.44 |
| 1 Month Change | -0.81% |
| 3 Month Change | 4.27% |
| 1 Year Change | 15.97% |
| 3 Year Change | -10.29% |
| 5 Year Change | 33.77% |
| Change since IPO | 626.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| DP3 | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -2.2% | -2.1% | -4.3% |
| 1Y | 16.0% | -11.2% | 6.4% |
Return vs Industry: DP3 exceeded the VN Pharmaceuticals industry which returned -11.2% over the past year.
Return vs Market: DP3 exceeded the VN Market which returned 6.4% over the past year.
Price Volatility
| DP3 volatility | |
|---|---|
| DP3 Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in VN Market | 6.9% |
| 10% least volatile stocks in VN Market | 2.3% |
Stable Share Price: DP3 has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: DP3's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Khai Nguyen | www.duocphamtw3.com |
Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturing of soaps, detergents, polishes, and toilet preparations.
Central Pharmaceutical Joint Stock Company No3 Fundamentals Summary
| DP3 fundamental statistics | |
|---|---|
| Market cap | ₫1.31t |
| Earnings (TTM) | ₫173.97b |
| Revenue (TTM) | ₫515.53b |
Is DP3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DP3 income statement (TTM) | |
|---|---|
| Revenue | ₫515.53b |
| Cost of Revenue | ₫173.97b |
| Gross Profit | ₫341.56b |
| Other Expenses | ₫167.59b |
| Earnings | ₫173.97b |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.09k |
| Gross Margin | 66.25% |
| Net Profit Margin | 33.75% |
| Debt/Equity Ratio | 3.7% |
How did DP3 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/28 01:23 |
| End of Day Share Price | 2026/07/28 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Central Pharmaceutical Joint Stock Company No3 is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | FPT Securities |